<DOC>
	<DOCNO>NCT02168062</DOCNO>
	<brief_summary>Randomized , phase 2 study assess impact multi-disciplinary STAND clinic change key metabolic parameter , quality life , patient satisfaction among men receive androgen deprivation therapy prostate cancer . Standard-of-care therapy consist every 3-month visit comprise review medical history , toxicity assessment , lifestyle modification counsel provide dietitian exercise physiologist as-needed basis . Men randomize participate multi-disciplinary STAND clinic , addition every 3-month visit individual health care provider , structure individualized exercise dietary counseling . A separate non-randomized patient cohort 20 patient receive concurrent chemohormonal therapy enrol parallel . The primary hypothesis study active participation multi-disciplinary clinic , compare current standard-of-care , lead lessen impact androgen deprivation therapy metabolic parameter improve quality life .</brief_summary>
	<brief_title>Multidisciplinary Study Androgen Deprivation Therapy ( ADT ) Prostate Cancer</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Prolactin Release-Inhibiting Factors</mesh_term>
	<mesh_term>Androgens</mesh_term>
	<criteria>Inclusion Criteria Histologic confirmation adenocarcinoma prostate Receiving planning receive ADT LHRH agonist antagonist Expected duration ADT least 12 month date study consent Concurrent antiandrogen therapy allow require First dose LHRH agonist antagonist 6 month prior date study consent Prior/concurrent radiation allow Other investigational agent addition LHRH agonist/antagonist allow ( e.g . novel antiandrogens , androgen synthesis inhibitor ) Prior androgen deprivation therapy allow , provide document evidence testosterone recovery &gt; 150 ng/dL great 12 month duration last `` effective '' date ADT date study consent ECOG performance status 0 2 Ability sign write informed consent Willing attend monthly clinic visit UCSF Randomized cohort : No prior chemotherapy within 12 month start date study No plan chemotherapy least 12 month study entry Nonrandomized pilot cohort : Concurrent chemotherapy ( initiate within 3 month study entry ) plan chemotherapy within 3 month study entry Exclusion Criteria Physically unable unwilling participate recommend exercise program travel UCSF monthly basis Presence permanent pacemaker implantable medical device ( artificial joint prosthesis venous filter allow )</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Supportive Therapy</keyword>
	<keyword>Androgen Deprivation Therapy</keyword>
</DOC>